Introduction: Flow cytometry (FC) enables rapid identification of cell lineages based on their fluorescent and light‐scattering properties, playing a critical role in diagnosing and monitoring oncohematological diseases. Standardization of procedures in spectral FC is essential for method validation studies. Methods: We designed a comparative study using 21 blood samples from healthy donors. Three commercial lysing solutions used in spectral FC immunophenotyping were evaluated. Samples were stained with a panel of eight antibody‐conjugated fluorochromes and aliquoted for assessment with each lysing solution (Excellyse I, Excellyse Easy, and Tombo RBC Lysis Buffer), following the manufacturers' protocols. Data acquisition was performed using a full‐spectrum flow cytometer. Results: An average cell loss of 31.4% was observed, with no statistically significant differences between lysing solutions, although Excellyse I showed lower cell loss under the no‐wash protocol. This reagent also achieved superior resolution in distinguishing lymphocytes from debris. It demonstrated the lowest coefficients of variation in both scatter and fluorescence parameters of leukocyte populations, highlighting its ability to preserve the optical characteristics of stained cells. RBC‐T performed well in specific channels such as APC and PE‐Cy7, whereas Excellyse Easy produced a resolution comparable to Excellyse I, albeit with greater signal dispersion. Conclusion: Excellyse I demonstrated the best overall performance, with greater cell preservation, clearer population resolution, and lower variability in scatter and fluorescence. Nonetheless, Excellyse Easy may still be considered a viable alternative.
30 September 2026 in Revista de la Facultad de Medicina Humana
Introduction: Some complete blood count–derived indices could be useful for assessing hemoglobinization abnormalities. Objective: To evaluate the diagnostic performance of the microcytic anemia factor (MAF) and low hemoglobin density (LHD%) for identifying hemoglobinization abnormalities consistent with iron-restricted erythropoiesis, using Ret-He <28 pg as the functional reference standard, in blood donor candidates. Methods: A retrospective cross-sectional diagnostic accuracy study was conducted, including 227 blood donor candidates evaluated at the Hemotherapy and Blood Bank Service of Hospital Cayetano Heredia, Lima, Peru. Participants were classified according to Ret-He <28 pg and Ret-He ≥28 pg. MAF and LHD% were calculated from complete blood count parameters. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis, and the area under the curve (AUC), sensitivity, and specificity were estimated. Results: Overall, 17.2% (39/227) of blood donor candidates had Ret-He 5.60, a sensitivity of 92.3%, and a specificity of 84.6%. No statistically significant difference was observed between the two ROC curves. Conclusions: MAF and LHD% showed good diagnostic performance for identifying low reticulocyte hemoglobinization in blood donor candidates. LHD% showed a more favorable screening profile because of its higher sensitivity, whereas MAF showed higher specificity.
Objetivo: Determinar la correlación entre la glucosa salival y marcadores de disfunción de célula beta en pacientes con Diabetes Mellitus tipo 2 (DM2). Materiales y métodos: Estudio transversal llevado a cabo en el Centro de Investigación en Diabetes, Obesidad y Nutrición (CIDON) en Lima, Perú durante el año 2021. Se categorizó en buen control metabólico (HbA1c<7%) y mal control metabólico (HbA1c≥7%). Se midió la glucosa basal, HbA1c y el péptido C en sangre. La glucosa salival se midió con el método glucosa-oxidasa. La correlación de Spearman fue usada para determinar la asociación entre la glucosa salival y los marcadores de disfunción de célula beta. Resultados: Participaron un total de 142 personas con DM2. La concentración de glucosa salival fue significativamente más elevada en DM2 con mal control metabólico (p<0.01). Se observó una correlación positiva débil significativa entre la glucosa salival y la glucosa basal (r=0.23, p=0.04) y HbA1c (r=0.26, p=0.02) en DM2 con mal control metabólico y una correlación negativa insignificante (r=-0.08; p=0.47) con el péptido C. Conclusiones: La glucosa salival presenta una asociación significativa y positiva con la glucosa en sangre y la HbA1c, pero no con el péptido C en personas con DM2 con mal control metabólico. Sin embargo, hay muchos factores que deben ser considerados y analizados más a fondo para determinar su posible uso.